MeSH tree: C06.405.205.731.249
Many patients with inflammatory bowel disease (IBD) suffer from abdominal pain even between acute inflammatory flare-ups. Altered processing of pain in response to fear may be involved. This is the conclusion of a research ...
Dec 12, 2025
0
14
A team led by scientists at King's College London, in collaboration with national and international partners, has discovered how a specific group of immune cells in the gut—Group 3 Innate Lymphoid Cells (ILC3s)—promote intestinal ...
Dec 11, 2025
0
13
The first week of December marks Crohn's & Colitis Awareness Week. Since 1990, cases of inflammatory bowel disease (IBD) have nearly doubled. It has risen fastest among those aged 15–39. IBD is a chronic inflammation of the ...
Nov 26, 2025
0
17
Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic inflammation and ulcers in the lining of the large intestine. This can lead to symptoms such as rectal ...
Women with inflammatory bowel disease (IBD) are three times more likely to forgo having children than people without the condition—it's a trend driven by fear and confusion about what the disease would mean for their pregnancies ...
Nov 19, 2025
0
8
CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells exacerbate inflammation and lead to chronic disease in certain conditions.
Nov 11, 2025
0
10
James Cook University (JCU) researchers have discovered that the same chemical compounds produced by mountain-top plants to help them survive climate change in North Queensland may also hold promise for treating inflammatory ...
Nov 11, 2025
0
15
For patients with inflammatory bowel disease (IBD), alterations in gut microbiota are associated with health-related quality of life (HRQoL) outcomes, according to a study published online Sept. 29 in The American Journal ...
Oct 22, 2025
0
12
Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in clinical care, according to a paper published in Journal of Medical Internet Research.
Oct 8, 2025
0
22
The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.
Sep 25, 2025
0
14
